Cargando…

Mortality and Heart Failure After Upgrade to Cardiac Resynchronization Therapy

BACKGROUND: Cardiac resynchronization therapy (CRT) is effective in treating advanced heart failure (HF), but data describing benefits and long-term outcomes for upgrades from a preexisting device are limited. This study sought to compare long-term outcomes in de novo CRT implants with those eligibl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beca, Bogdan, Sapp, John L., Gardner, Martin J., Gray, Christopher, AbdelWahab, Amir, MacIntyre, Ciorsti, Doucette, Steve, Parkash, Ratika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063653/ https://www.ncbi.nlm.nih.gov/pubmed/32159089 http://dx.doi.org/10.1016/j.cjco.2019.02.002

Ejemplares similares

The Effect of Shock Burden on Heart Failure and Mortality
por: MacIntyre, Ciorsti J., et al.
Publicado: (2019)

The effect of revascularization on mortality and risk of ventricular arrhythmia in patients with ischemic cardiomyopathy
por: Alkharaza, Ahmad, et al.
Publicado: (2020)

Prevalence and management of electrical lead abnormalities in cardiac implantable electronic device leads
por: Roberts, Hilary, et al.
Publicado: (2023)

A virtual platform to deliver ambulatory care for patients with atrial fibrillation
por: Weng, Willy, et al.
Publicado: (2020)

An Integrated Management Approach to Atrial Fibrillation
por: Carter, Lindsey, et al.
Publicado: (2016)

Polymorphic ventricular tachycardia due to change in pacemaker programming
por: Elsokkari, Ihab, et al.
Publicado: (2017)

Remote Monitoring of Cardiovascular Implantable Electronic Devices in Canada: Survey of Patients and Device Health Care Professionals
por: Kelly, Shannon E., et al.
Publicado: (2020)

Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society
por: Sapp, John L., et al.
Publicado: (2020)

Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: a randomized trial
por: Merkely, Béla, et al.
Publicado: (2023)

Remote-only monitoring for patients with cardiac implantable electronic devices: a before-and-after pilot study
por: Sapp, John A., et al.
Publicado: (2021)

Cardiac resynchronization in pacing-associated cardiomyopathy: Is it time to upgrade?
por: Hutchinson, Mathew D.
Publicado: (2021)

Comparison of De Novo versus Upgrade Cardiac Resynchronization Therapy; Focused on the Upgrade for Pacing-Induced Cardiomyopathy
por: Gwag, Hye Bin, et al.
Publicado: (2017)

An unusual failure of cardiac resynchronization therapy
por: Higuchi, Satoshi, et al.
Publicado: (2022)

Improving localization accuracy for non-invasive automated early left ventricular origin localization approach
por: Zhou, Shijie, et al.
Publicado: (2023)

The therapeutic benefit of upgrade to cardiac resynchronization therapy in patients with pacing-induced cardiomyopathy
por: Kerley, Robert N., et al.
Publicado: (2023)

Long-term mortality in cardiac resynchronization therapy upgrade procedures compared with de novo implantations - a nationwide cohort study
por: Bjerre, H L, et al.
Publicado: (2023)

Rhythm Control Vs Rate Control in a Contemporary Ambulatory Atrial Fibrillation Cohort: Post Hoc Analysis of the IMPACT-AF Trial
por: Govindapillai, Arun, et al.
Publicado: (2022)

Left ventricular markers of mortality and ventricular arrhythmias in heart failure patients with cardiac resynchronization therapy
por: Hasselberg, Nina E., et al.
Publicado: (2016)

Sex-specific mortality differences in heart failure patients with ischemia receiving cardiac resynchronization therapy
por: Han, Zhonglin, et al.
Publicado: (2017)

Cardiac resynchronization therapy improved the clinical outcomes in pacemaker patients upgraded to biventricular device
por: Jin, Han, et al.
Publicado: (2017)

Unanswered questions about the Middle East respiratory syndrome coronavirus (MERS-CoV)
por: Gardner, Lauren M, et al.
Publicado: (2014)

Cardiac Resynchronization Therapy Vegetations
por: Hamada, Abdel Haleem Shawky, et al.
Publicado: (2023)

Reparative resynchronization in ischemic heart failure: an emerging strategy
por: Yamada, Satsuki, et al.
Publicado: (2014)

Interleukin-6 signaling in patients with chronic heart failure treated with cardiac resynchronization therapy
por: Ptaszynska-Kopczynska, Katarzyna, et al.
Publicado: (2016)

Cardiac Resynchronization Therapy prevents progression of renal failure in heart failure patients
por: Jeevanantham, Vinodh, et al.
Publicado: (2016)

Upgrade of cardiac resynchronization therapy by utilizing additional His-bundle pacing in patients with inotrope-dependent end-stage heart failure: a case series
por: Baba, Masako, et al.
Publicado: (2020)

Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience
por: Kutyifa, Valentina, et al.
Publicado: (2014)

The role of brain natriuretic peptide in atrial fibrillation: a substudy of the Substrate Modification with Aggressive Blood Pressure Control for Atrial Fibrillation (SMAC-AF) trial
por: Weng, Willy, et al.
Publicado: (2021)

Cardiac resynchronization therapy in heart failure patients with atrial fibrillation
por: Gasparini, Maurizio, et al.
Publicado: (2009)

Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure
por: Osmanska, Joanna, et al.
Publicado: (2018)

Outcomes of Cardiac Resynchronization Therapy in Patients with Hypothyroidism and Heart Failure
por: Yang, Mei, et al.
Publicado: (2020)

Cardiac resynchronization therapy with or without defibrillator in patients with heart failure
por: Schrage, Benedikt, et al.
Publicado: (2021)

Highly Pathogenic Avian Influenza Virus, Midwestern United States
por: Bui, Chau M., et al.
Publicado: (2016)

De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis
por: Kosztin, Annamaria, et al.
Publicado: (2017)

Long-term clinical outcomes after upgrade to resynchronization therapy: A propensity score–matched analysis
por: Brandão, Mariana, et al.
Publicado: (2021)

Cardiac Magnetic Resonance, Electromechanical Activation, Kidney Function, and Natriuretic Peptides in Cardiac Resynchronization Therapy Upgrades
por: Bivona, Derek J., et al.
Publicado: (2023)

Phenogrouping and risk stratification of patients undergoing cardiac resynchronization therapy upgrade using topological data analysis
por: Schwertner, Walter Richard, et al.
Publicado: (2023)

Eating Timing and Frequency as a Predictor of Hospitalization and/or Mortality From Coronary Artery Disease: The Linked CCHS-DAD-CMDB 2004-2013 Study
por: Carew, Allie S., et al.
Publicado: (2022)

Influenza A H5N1 and H7N9 in China: A spatial risk analysis
por: Bui, Chau Minh, et al.
Publicado: (2017)

Sex and racial disparities in catheter ablation
por: Vandenberk, Bert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3k4db9kkpl5nguf01tfoq42ncg